The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

A beginner's guide to R.

Bedogni G.

Journal of The Royal Statistical Society: SeriesA, July;173:697

2010

Clinical Prediction Models: a practical approach to development, validation and updating

Bedogni G.

Journal of The Royal Statistical Society: Series A;172:944 (Book review)

2009

Statistical models: theory and practice (revised edition)

Bedogni G.

Significance ;4:188 (Book review).

2009

Modern Regression Methods

Bedogni G.

Journal of The Royal Statistical Society: Series A; 6:275 (Book review).

2009

Biochemical investigations in the management of liver disease

Rigato I, Ostrow JD and Tiribelli C
In "Textbook of Hepatology: From Basic Science to Clinical Practice" 3rd Edition. Edited by Juan Rodés, Jean-Pierre Benhamou, Andres Blei, Jurg Reichen and Mario Rizzetto. Backwel Publisdhing, Oxford, UK N° [Pag. ]
2007

Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children

P.Brambilla, G. Bedogni, LA Moreno, MI Goran, B Gutin, KR Fox, DM Peters, P Barbeau, M De Simone and A Pietrobelli.
International Journal of Obesity N°30 [Pag. 23-30]
2006

The assessment of body composition in health and disease

Bedogni G, Brambilla P, Bellentani S, Tiribelli C.
Human Ecology Special Issue (Kaushik Bose, Guest Editor) N°14 [Pag. 21-25]
2006

Disturbances of bilirubin metabolism

Cekic D, Rigato I, and Tiribelli C.
In "Clinical Gastroenterology and Hepatology". By: WM Weinstein, CJ Hawkey, J Bosch Eds. Elsevier Mosby, Philadelphia, USA. N° [Pag. 693-698]
2005

Metabolismo y alteraciones de la bilirrubina

Bayon JE, Pascolo L, and Tiribelli C.
In: Conceptos actuales en hepatologia. By: Mendez-Sanchez N and Uribe M Ed.Masson Doyma, Mexico N° [Pag. 71-81]
2003

Alcohol and Nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, and Bedogni G.
In: "Nutrition and Alcohol: Linking Nutrient Interactions and Dietary Intake"By: RR Watson and VR Preedy Ed. CRC Press, Boca Raton, FL, USA N° [Pag. 73-85]
2003

Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: A new pathway of neurotoxicity

Rauti R, Qaisiya M, Tiribelli C, Ballerini L, Bellarosa C

Arch Toxicol. 2020 Mar;94(3):845-855. doi: 10.1007/s00204-020-02659-9. Epub 2020 Mar 3.

2020

The importance of transaminases flare in liver elastography: Characterization of the probability of liver fibrosis overestimation by hepatitis C virus-induced cytolysis

Giuffrè M, Fouraki S, Comar M, Masutti F, Crocè LS

Microorganisms 2020 Feb 29;8(3):348 doi: 103390/microorganisms8030348

2020

Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy

Gurian E, Giraudi P, Rosso N, Tiribelli C, Bonazza D, Zanconati F, Giuricin M, Palmisano S, de Manzini N, Sergo V, Bonifacio A

Anal Chim Acta. 2020 May 8;1110:190-198.doi: 10.1016/j.aca.2020.02.040

2020

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR analysis of serum microRNA expression in hepatocellular carcinoma

Pratama MY, Cavalletto L, Tiribelli C, Chemello L, Pascut D

Sci Rep. 2020 Feb 21;10(1):3128. doi: 10.1038/s41598-020-59682-0

2020

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro mode

Anfuso B, Tiribelli C, Adorini L, Rosso N

Sci Rep. 2020 Feb 3;10(1):1699. doi: 10.1038/s41598-020-58562-x

2020

Fatty liver, cardiometabolic disease and mortality

Bedogni G, Gastaldelli A, Foschi FG

Curr Opin Lipidol, 2020 Feb;31(1):27-31.doi: 10.1097/MOL.0000000000000652.

2020

Is Parkinson’s disease an unique clinical entity? Rigid or tremor dominant PD: Two faces of the same coin

Caruso P, Monguzzi G, Sala A, Dal Ben M, Gazzin S

J Clin Neurosci. 2020 Apr;74:18-24. doi: 10.1016/j.jocn.2020.01.068

2020

Associations among taste perception, food neophobia and preferences in type 1 diabetes children and adolescents: A cross-sectional study

Mameli C, Cattaneo C, Lonoce L, Bedogni G, Redaelli FC, Macedoni M, Zuccotti G, Pagliarini E

Nutrients. 2019 Dec 13;11(12):3052. doi: 10.3390/nu11123052.

2019

Sex- and age-related differences in the contribution of ultrasound-measured visceral and subcutaneous abdominal fat to fatty liver index in overweight and obese Caucasian adults

Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S

Nutrients. 2019 Dec 9;11(12). pii: E3008. doi: 10.3390/nu11123008

2019

Serum miRNA are promising biomarkers for the detection of early hepatocellular carcinoma after treatment with direct-acting antivirals

Pascut P, Cavalletto L, Pratama MY, Bresolin S, Trentin L, Basso G, Bedogni G, Tiribelli C, Chemello L

Cancers (Basel). 2019 Nov 11;11(11). pii: E1773. doi: 10.3390/cancers11111773

2019

 

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.

2017

Treatments for non-alcoholic steatohepatitis - still a long way to go

 Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)

2017

Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice

Moretti R, Caruso P, Crisman E, Gazzin S

Neurol India. Jul-Aug;65(4):814-825. doi: 10.4103/neuroindia.NI_850_16

2017

Is it time to change NAFLD and NASH nomenclature?

Bellentani S, Tiribelli C

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):547-548. doi: 10.1016/S2468-1253(17)30146-2

2017

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health

Martini D, Rossi S, Biasini B, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Di Nuzzo S, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Del Rio D

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):473-503. doi: 10.1016/j.numecd.2017.01.008. Epub 2017 Feb 13

2017

The molecular basis of jaundice: An old symptom revisited

Gazzin S, Masutti F, Vitek L, Tiribelli C

Liver Int. doi: 10.1111/liv.13351.

2016